research use only
Cat.No.S4852
|
In vitro |
DMSO
: 100 mg/mL
(106.6 mM)
Water : 10 mg/mL |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 938 | Formula | C14H18GdN3O10.2C7H17NO5.2H |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 86050-77-3 | -- | Storage of Stock Solutions |
|
|
| Synonyms | Gadopentetic acid dimeglumine, Gd-DTPA, Meglumine gadopentetate | SMILES | CNCC(O)C(O)C(O)C(O)CO.CNCC(O)C(O)C(O)C(O)CO.OC(=O)CN1CCN2CCN(CC(O)=O)CC(=O)O[Gd](OC(=O)C2)OC(=O)C1 | ||
Read more about storage stability stock solution CAS number SMILES
(data from https://clinicaltrials.gov, updated on 2023-12-12)
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT00375830 | COMPLETED | Cancer |
Stanford University |
2006-01 | PHASE2 |
| NCT02371798 | WITHDRAWN | Meniere Disease |
Emory University |
2015-02 | |
| NCT02967380 | TERMINATED | Adult Anaplastic (Malignant) Meningioma; Adult Anaplastic Astrocytoma; Adult Anaplastic Ependymoma; Adult Anaplastic Oligodendroglioma; Adult Brain Stem Glioma; Adult Choroid Plexus Neoplasm; Adult Diffuse Astrocytoma; Adult Ependymoblastoma; Adult Ependymoma; Adult Giant Cell Glioblastoma; Adult Glioblastoma; Adult Gliosarcoma; Adult Grade II Meningioma; Adult Medulloblastoma; Adult Mixed Glioma; Adult Oligodendroglioma; Adult Papillary Meningioma; Adult Pineal Gland Astrocytoma; Adult Pineoblastoma; Adult Primary Melanocytic Lesion of Meninges; Adult Supratentorial Primitive Neuroectodermal Tumor; Malignant Adult Intracranial Hemangiopericytoma; Metastatic Malignant Neoplasm in the Brain; Multiple Sclerosis; Recurrent Adult Brain Neoplasm |
University of Southern California |
2011-12-14 | |
| NCT02175069 | COMPLETED | Disorder of Shoulder |
Paracelsus Medical University |
2013-12 | PHASE4 |
| NCT02080312 | COMPLETED | Meniere's Disease |
University of California, San Diego |
2012-01 | |
| NCT02775786 | Active not recruiting | Pancreatic Adenocarcinoma |
Columbia University |
2013-11 | Not Applicable |
Read more about Clinical Trials
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.